Archives concert-pharmaceuticals

by in
Entry Author Date Location
East Coast Biotech Roundup: NY Bio, Synageva, Kadmon & More 05/08/15 New York
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
Big Events, Exits Raising Boston’s Innovation Profile at Year’s End 12/12/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks 07/01/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
East Coast Life Sciences Roundup: Dunsire, Good Start, Nimbus, & More 05/10/13 Boston
Concert Pharma To Get $300M+ Per Drug in Celgene Pact 05/06/13 Boston
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist 03/01/13 Boston
Concert Pharma, Jazz Pharma Strike $120M Deal for Narcolepsy 02/26/13 Boston
BG Medicine, Bottomline, 4s3 Bioscience Among the Week’s Dealmakers 03/07/12 Boston
Concert, Alere, TremRx, & More Names from Boston Life Sciences News 03/02/12 Boston
SD Life Sciences (and Cleantech) Roundup: DexCom, Ligand, Genomatica 03/01/12 San Diego
Concert Nabs $200M Deal From Avanir to Make Psych Drugs 02/29/12 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance 06/20/11 Boston
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund 01/06/11 Boston
How Eli Lilly Let a Billion-Dollar Molecule Slip Away and Make a Fortune for Vertex 08/04/10 Boston
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News 07/16/10 Boston
Concert Pharma Riding Potential $1B Glaxo Deal, Looks Ahead to Human Data on HIV Drug 07/14/10 Boston
XSITE’s Biotech Gurus to Cover the State of New England Biotech, the Return of Platforms 06/07/10 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Sirtris Vet Michelle Dipp Takes Over Key Role at Glaxo as Westphal Returns to VC 04/22/10 Boston
Page 1 of 2 next page »